BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 34155783)

  • 1. Hepatocellular adenoma in men: A nationwide assessment of pathology and correlation with clinical course.
    van Rosmalen BV; Furumaya A; Klompenhouwer AJ; Tushuizen ME; Braat AE; Reinten RJ; Ligthart MAP; Haring MPD; de Meijer VE; van Voorthuizen T; Takkenberg RB; Dejong CHC; de Man RA; IJzermans JNM; Doukas M; van Gulik TM; Verheij J;
    Liver Int; 2021 Oct; 41(10):2474-2484. PubMed ID: 34155783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathologic characterization of hepatocellular adenomas in men: a multicenter experience.
    González IA; Torbenson M; Sharifai N; Byrnes K; Chatterjee D; Kakar S; Yeh MM; Wu TT; Zhang X; Jain D
    Hum Pathol; 2023 Aug; 138():24-33. PubMed ID: 37245629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcomes following resection of hepatocellular adenomas with small foci of malignant transformation or malignant adenomas.
    Chopinet S; Cauchy F; Hobeika C; Beaufrère A; Poté N; Farges O; Dokmak S; Bouattour M; Ronot M; Vilgrain V; Paradis V; Soubrane O
    JHEP Rep; 2021 Aug; 3(4):100326. PubMed ID: 34368664
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Longerich T; Endris V; Neumann O; Rempel E; Kirchner M; Abadi Z; Uhrig S; Kriegsmann M; Weiss KH; Breuhahn K; Mehrabi A; Weber TF; Wilkens L; Straub BK; Rosenwald A; Schulze F; Brors B; Froehling S; Pellegrino R; Budczies J; Schirmacher P; Stenzinger A
    Gut; 2019 Jul; 68(7):1287-1296. PubMed ID: 30901310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and epigenetic analysis of hepatocellular adenomas with atypical morphological features.
    Haefliger S; Hench J; O'Rourke CJ; Meyer-Schaller N; Uzun S; Saldarriaga J; Weber A; Mazzucchelli L; Jermann P; Frank S; Andersen JB; Terracciano L; Sempoux C; Matter MS
    Histopathology; 2023 Apr; 82(5):722-730. PubMed ID: 36583256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular adenomas in a large community population, 2000 to 2010: reclassification per current World Health Organization classification and results of long-term follow-up.
    Shafizadeh N; Genrich G; Ferrell L; Kakar S
    Hum Pathol; 2014 May; 45(5):976-83. PubMed ID: 24746201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation.
    Nault JC; Couchy G; Balabaud C; Morcrette G; Caruso S; Blanc JF; Bacq Y; Calderaro J; Paradis V; Ramos J; Scoazec JY; Gnemmi V; Sturm N; Guettier C; Fabre M; Savier E; Chiche L; Labrune P; Selves J; Wendum D; Pilati C; Laurent A; De Muret A; Le Bail B; Rebouissou S; Imbeaud S; ; Bioulac-Sage P; Letouzé E; Zucman-Rossi J
    Gastroenterology; 2017 Mar; 152(4):880-894.e6. PubMed ID: 27939373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocellular adenomas: review of pathological and molecular features.
    Beaufrère A; Paradis V
    Hum Pathol; 2021 Jun; 112():128-137. PubMed ID: 33307077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Borderline Hepatocellular Adenomas: A Practical Diagnostic Approach Based on Pathologic and Molecular Features.
    Poté N; Caruso S; Caderaro J; Cauchy F; Lagadec F; Couchy G; Raffenne J; Augustin J; Vernuccio F; Vilgrain V; Hercent A; Theou-Anton N; Zucman-Rossi J; Paradis V
    Mod Pathol; 2023 Sep; 36(9):100211. PubMed ID: 37169258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocellular adenoma classification: a comparative evaluation of immunohistochemistry and targeted mutational analysis.
    Margolskee E; Bao F; de Gonzalez AK; Moreira RK; Lagana S; Sireci AN; Sepulveda AR; Remotti H; Lefkowitch JH; Salomao M
    Diagn Pathol; 2016 Mar; 11():27. PubMed ID: 26961851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changing trends in malignant transformation of hepatocellular adenoma.
    Farges O; Ferreira N; Dokmak S; Belghiti J; Bedossa P; Paradis V
    Gut; 2011 Jan; 60(1):85-9. PubMed ID: 21148580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocellular adenomas in the Turkish population: reclassification according to updated World Health Organization criteria.
    Deniz K; Umetsu SE; Ferrell L; Yılmaz F; Güllüoğlu M; Sağol Ö; Doğusoy GB; Kırımlıoğlu H; Turhan N; Doran F; Kepil N; Çelikel ÇA; Nart D; Özgüven BY; Ceyran B; Karadağ N; Kır G; Erden E; Yılmaz G; Akyol G
    Histopathology; 2021 Jul; 79(1):23-33. PubMed ID: 33406290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of hepatocellular adenoma and carcinoma using microRNA profiling and targeted gene sequencing.
    Zheng J; Sadot E; Vigidal JA; Klimstra DS; Balachandran VP; Kingham TP; Allen PJ; D'Angelica MI; DeMatteo RP; Jarnagin WR; Ventura A
    PLoS One; 2018; 13(7):e0200776. PubMed ID: 30052636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective study on timing of resection of hepatocellular adenoma.
    Klompenhouwer AJ; Bröker MEE; Thomeer MGJ; Gaspersz MP; de Man RA; IJzermans JNM
    Br J Surg; 2017 Nov; 104(12):1695-1703. PubMed ID: 28857134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subtype classification of hepatocellular adenoma.
    Bioulac-Sage P; Balabaud C; Zucman-Rossi J
    Dig Surg; 2010; 27(1):39-45. PubMed ID: 20357450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of patients with hepatocellular adenoma: a single-institution experience.
    Nahm CB; Parker N; Gundara JS; Gill AJ; Bhimani N; Samra JS; Hugh TJ
    ANZ J Surg; 2020 May; 90(5):786-790. PubMed ID: 31943651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical hepatocellular adenoma-like neoplasms with β-catenin activation show cytogenetic alterations similar to well-differentiated hepatocellular carcinomas.
    Evason KJ; Grenert JP; Ferrell LD; Kakar S
    Hum Pathol; 2013 May; 44(5):750-8. PubMed ID: 23084586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry.
    Bioulac-Sage P; Rebouissou S; Thomas C; Blanc JF; Saric J; Sa Cunha A; Rullier A; Cubel G; Couchy G; Imbeaud S; Balabaud C; Zucman-Rossi J
    Hepatology; 2007 Sep; 46(3):740-8. PubMed ID: 17663417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OATPB1/B3 and MRP3 expression in hepatocellular adenoma predicts Gd-EOB-DTPA uptake and correlates with risk of malignancy.
    Sciarra A; Schmidt S; Pellegrinelli A; Maggioni M; Dondossola D; Pasquier J; Cigala C; Tosi D; Halkic N; Bulfamante G; Viale G; Bosari S; Balabaud C; Bioulac-Sage P; Sempoux C
    Liver Int; 2019 Jan; 39(1):158-167. PubMed ID: 30218633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole-exome sequencing-based mutational profiling of hepatocellular adenoma malignant transformation to hepatocellular carcinoma.
    Bu Y; Huang R; Gao J; Qu W; Fu X; Liu W; Ding Z; Zhou J; Fan J; Wang X; Chen D; Tang Z
    Clin Exp Pharmacol Physiol; 2024 Jul; 51(7):e13901. PubMed ID: 38843867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.